By Liz MoyerInvesting.com -- Pfizer Inc (NYSE:PFE) shares rose after the Food and Drug Administration approved its Covid-19 booster shot for children aged 5 to 11. Pfizer...
Shares of Moderna (NASDAQ:MRNA) are up 5% in premarket trading Wednesday after the company reported better-than-expected Q1 revenue.The pharmaceutical company reported a Q1...
Pre-Open Stock Movers:Livent Corporation (NYSE:LTHM) 26% HIGHER; reported Q1 EPS of $0.28, $0.15 better than the analyst estimate of $0.13. Revenue for the quarter came in at...
Moderna reported Q1 results May 4, beating earnings expectations by more than 60%Shares are 72% below the 12-month high closing price hit Aug. 9Consensus rating is bullish, with...
Stocks on Wall Street plunged on Friday, with the tech-heavy NASDAQ Composite suffering its worst month since 2008, as technology shares sank following disappointing earnings and...
Investors will be bracing for another volatile week in the stock market this week on signs that ongoing bearish sentiment has more room to run, especially when an adverse...
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Strong Sell | Sell | Neutral |
| Technical Indicators | Buy | Strong Sell | Strong Sell | Neutral | Sell |
| Summary | Neutral | Strong Sell | Strong Sell | Neutral | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.20 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 13.74 | 13.74 | 13.74 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 22.25 | 22.30 | 22.25 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 7.00 | 7.00 | 7.00 | +0.45 | +6.87% | 1.12M | Lagos | |||
| 232.00 | 232.00 | 232.00 | -2.50 | -1.07% | 42.24K | Lagos | |||
| 23.85 | 23.90 | 23.90 | -0.05 | -0.21% | 11.85M | Lagos | |||
| 12.00 | 11.95 | 11.85 | +0.05 | +0.42% | 1.06M | Lagos | |||
| 30.45 | 30.00 | 30.00 | -0.50 | -1.64% | 345.31K | Lagos | |||
| 6.20 | 6.29 | 6.08 | +0.01 | +0.16% | 2.51M | Lagos | |||
| 2.30 | 2.25 | 2.25 | -0.050 | -2.17% | 1.12M | Lagos | |||
| 4.55 | 4.31 | 4.30 | +0.010 | +0.23% | 695.97K | Lagos | |||
| 8.00 | 8.05 | 8.00 | -0.15 | -1.84% | 1.28M | Lagos | |||
| 1.29 | 1.40 | 1.25 | -0.080 | -6.02% | 23.20M | Lagos | |||
| 180.00 | 180.00 | 180.00 | 0.00 | 0.00% | 627.27K | Lagos | |||
| 34.80 | 34.80 | 34.80 | +1.80 | +5.45% | 11.40K | Lagos |